Back to search

United Kingdom· GB-APID-4380511000001101

Flixonase Nasule 400microgram/unit dose nasal drops

A fluticasone product containing fluticasone, registered in United Kingdom by GlaxoSmithKline UK Ltd. The same ATC class is registered in 14 of our 19 countries.

ATC R01AD08

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedFlixonase Nasule 400microgram/unit do…ATCR01AD08REGISTER NO.GB-APID-4380511000001…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Fluticasone is registered in 14 of 19 countries.

Countries holding a registration under ATC R01AD08 (fluticasone), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 8 of them publish a price we can compare per daily dose

Fluticasone · ATC R01AD08

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Fluticasone
Manufacturer
GlaxoSmithKline UK Ltd
Country
United Kingdom (GB)
ATC code
R01AD08
ATC class
Fluticasone
Defined daily dose
0.2 mg, N
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5000124440855

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

55 interactions on record for fluticasone.

Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Fluticasone · interactions on record

55 records

  • 29 severe
  • 25 moderate
  • 1 minor

Most severe, free to view

  • LonafarnibA16AX20severe
  • ConivaptanC03XA02severe
  • KetoconazoleH02CA03severe
  • TroleandomycinJ01FA08severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fluticasone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fluticasone products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Flixonase Aquosum, Flixotide Diskus Forte
  • Belgium · Flixonase Aqua, Flixotide
  • Bulgaria · Аркуист, Фликсоназе
  • Cyprus · Cutivate, Flixonase Aqueous
  • Czechia · Flixotide Diskus, Flixotide Inhaler N
  • Germany · Flutica, Fluticason Cipla
  • Denmark · Flixotide, Flurhin
  • Estonia · Cutivate Cream, Flixonase
  • Spain · Avancort, Flixonase
  • Finland · Flixonase, Flixotide Diskus
  • France · Fixorinox, Flixonase
  • Greece · Alerxem, Bocacort-S
  • Croatia · Flixonase, Flixotide Inhaler
  • Hungary · Cutivate, Flixonase
  • Ireland · Arquist, Flixonase Allergy Relief
  • Iceland · Avamys, Flixotide
  • Italy · Aktanos, Deflut
  • Liechtenstein · Avamys
  • Lithuania · Cutivate, Flixotide
  • Luxembourg · Flixonase Aqua, Flixotide
  • Latvia · Flixonase, Flixotide
  • Malta · Cutivate, Flihaler
  • Netherlands · Cortifil, Cutivate
  • Norway · Avamys, Flurhin
  • Poland · Cutivate, Fanipos
  • Portugal · Brisovent Diskus, Brisovent Inalador
  • Romania · Arquist, Cutivate
  • Sweden · Arquist, Fluticasone Cipla
  • Slovenia · Flixonase, Flixotide
  • Slovakia · Flixonase Aqueous, Flixotide Diskus

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dac1fe51-64c5-4ce0-84d5-d5bf871d3a83
GET /v1/drugs/dac1fe51-64c5-4ce0-84d5-d5bf871d3a83?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "4380511000001101",
  "desc": "Flixonase Nasule 400microgram/unit dose nasal drops (GlaxoSmithKline UK Ltd)",
  "form": "Nasal drops",
  "vpid": "38894911000001100",
  "source": "dmd",
  "vtm_id": "776016008",
  "strength": "400 microgram",
  "substance": "Fluticasone",
  "ingredient": "Fluticasone propionate",
  "supplier_code": "4012301000001105"
}

See everything about fluticasone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.